Clinical Trials on Hodgkins Lymphoma in Norway
Total 148 results
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital; Norwegian Cancer SocietyActive, not recruitingChildhood Acute Lymphoblastic Leukemia | Childhood Acute Myeloid Leukemia | Childhood Non-Hodgkin LymphomaNorway
-
Biotec Pharmacon ASACompletedNon-Hodgkin's LymphomaNorway
-
Nordic NanovectorICON Clinical ResearchCompletedFollicular Lymphoma | Non Hodgkin Lymphoma | Relapsed Follicular LymphomaCzechia, Norway
-
Oslo University HospitalMerck Sharp & Dohme LLC; Norwegian Cancer SocietyCompleted
-
Oslo University HospitalNorwegian Cancer Society; Helse Sor-OstCompletedFollicular LymphomaNorway
-
Oslo University HospitalUniversity of OsloUnknown
-
Oslo University HospitalCompleted
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Oslo University HospitalAarhus University Hospital; Hoffmann-La RocheRecruitingLymphoma, FollicularNorway, Finland
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and TechnologyCompletedCutaneous T-Cell Lymphoma, Unspecified | Chronic Graft Versus Host Disease in SkinNorway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Nordic Lymphoma GroupActive, not recruitingRelapsed Non Hodgkin LymphomaNorway, Sweden, Finland, Denmark
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedLymphoma, Non-Hodgkin | Central Nervous System NeoplasmsNorway
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
BayerCompletedLymphoma, Non-HodgkinBelgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Australia, Brazil, Canada, Mexico, New Zealand, Peru
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
University of GiessenDeutsche Krebshilfe e.V., Bonn (Germany); Euronet WorldwideActive, not recruitingClassical Hodgkin LymphomaUnited Kingdom, Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Spain, Sweden, Switzerland
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...Active, not recruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Russian Federation, United Kingdom, Brazil, Ecuador, Germany, Slovenia, Spain, Norway, Switzerland, France, Hungary, Romania, Austria, Albania, Bulgaria, Slovakia, Sweden, Turkey, Argentina, Colombia, Greece, Egypt, Lithuania
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Stichting Hemato-Oncologie voor Volwassenen Nederland and other collaboratorsCompletedLymphomaFrance, Netherlands, United Kingdom, Australia, Canada, Norway, Poland, Belgium, Italy, New Zealand, Denmark, Egypt, Hungary, Portugal, Slovakia, Slovenia, South Africa, Sweden
-
Nordic Lymphoma GroupHelsinki University Central Hospital; Aarhus University HospitalRecruitingLymphoma, Large B-Cell, DiffuseDenmark, Norway, Sweden, Finland
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMature B-cell Non-Hodgkin LymphomaAustria, Czechia, Denmark, Finland, Germany, Norway, Sweden, Switzerland
-
Nordic Lymphoma GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | MCLFinland, Sweden, Norway, Denmark, Korea, Republic of
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
SanofiCompletedDiffuse Large B-Cell LymphomaNorway, Austria, France
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingLymphoblastic Lymphoma, ChildhoodSpain, Austria, Denmark, Finland, Germany, Belgium, Switzerland, China, Czechia, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden
-
Novartis PharmaceuticalsCompletedNon-Hodgkin LymphomaJapan, Spain, Germany, Australia, Austria, Canada, Italy, Norway, United States, United Kingdom, Finland, France, Denmark, Netherlands
-
Swiss Group for Clinical Cancer ResearchNordic Lymphoma GroupTerminatedFollicular LymphomaSweden, Finland, Denmark, Norway, Switzerland, Austria
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingSplenic Marginal Zone LymphomaSpain, Denmark, France, Norway, Switzerland, Sweden, Italy
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
Oslo University HospitalUnknownAcute Lymphoblastic Leukemia | ThromboembolismNorway
-
Novartis PharmaceuticalsActive, not recruitingFollicular LymphomaUnited States, Spain, Belgium, Japan, Australia, Germany, Italy, Netherlands, Norway, United Kingdom, Austria, France
-
Aarhus University HospitalGCP-unit at Aarhus University Hospital, Aarhus, DenmarkCompletedLymphoma, T-Cell, PeripheralNorway, Belgium, Finland, Denmark, Austria, Czechia, Portugal, Germany, Netherlands, Poland, Sweden
-
Bristol-Myers SquibbCompletedLymphomaAustralia, Italy, United States, Spain, Canada, United Kingdom, Germany, Belgium, France, Singapore, Sweden, Norway
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Incyte CorporationRecruitingDiffuse Large B-Cell Lymphoma | Large B-Cell LymphomaCroatia, Serbia, Czechia, Finland, Israel, Romania, Denmark, Hungary, Ireland, Poland, Turkey, Bulgaria, Norway, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States